Phibro Animal Health (NASDAQ:PAHC) Reaches New 1-Year High - Still a Buy?

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) reached a new 52-week high on Tuesday . The stock traded as high as $30.59 and last traded at $29.90, with a volume of 557250 shares. The stock had previously closed at $28.00.

Analysts Set New Price Targets

PAHC has been the subject of several research analyst reports. BNP Paribas Exane raised Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective for the company in a research report on Monday, June 16th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and upped their price objective for the company from $25.00 to $35.00 in a research report on Monday. Finally, Morgan Stanley set a $26.00 price objective on shares of Phibro Animal Health and gave the company an "equal weight" rating in a research report on Wednesday, June 25th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $24.40.

Phibro Animal Health Trading Down 1.1%

The company has a market cap of $1.25 billion, a price-to-earnings ratio of 39.49, a PEG ratio of 0.52 and a beta of 0.75. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.23 and a current ratio of 2.91. The business's 50 day moving average price is $24.79 and its 200-day moving average price is $22.44.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. The company had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%. On average, research analysts forecast that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, June 4th. This represents a $0.48 annualized dividend and a yield of 1.56%. Phibro Animal Health's dividend payout ratio is currently 61.54%.

Hedge Funds Weigh In On Phibro Animal Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Phibro Animal Health by 0.4% in the first quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company's stock valued at $32,500,000 after buying an additional 6,784 shares in the last quarter. Acadian Asset Management LLC increased its holdings in Phibro Animal Health by 0.5% during the 1st quarter. Acadian Asset Management LLC now owns 782,939 shares of the company's stock valued at $16,713,000 after purchasing an additional 4,144 shares in the last quarter. American Century Companies Inc. lifted its position in Phibro Animal Health by 18.0% during the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock worth $13,348,000 after buying an additional 96,787 shares in the last quarter. Nuveen Asset Management LLC lifted its position in Phibro Animal Health by 21.4% during the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after buying an additional 103,618 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its position in Phibro Animal Health by 1.9% during the 4th quarter. Renaissance Technologies LLC now owns 557,800 shares of the company's stock worth $11,714,000 after buying an additional 10,600 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.